Medical Research and Evaluation Facility (MREF) and Studies Supporting theMedical Chemical Defense Program. Comparison of HI-6 and 2-PAM Treatment Regimens in Rhesus Monkeys Challenged with Known Threat Nerve Agents. Task 91-25

摘要

Strong and well-defined agent dose l0-hr lethality relations were observed inuntreated animals for each agent. The lO-hr agent MLDs for untreated monkeys were estimated to be 80, 43, 8.0, 22, and 7.4 ug/kg for GA, GB, GD, GF, and VX, respectively. The l0-hr GD MLDs estimated for ATR/2-PAM and ATR/HI-6 treated monkeys were 10 and 13 ug/kg, respectively. Neither oxime provided protection against 2 x GD l0-hr MLD. No lethality was observed in oximetreated animals injected with either GF or VX, even though animals were given doses greater than 15 x agent MLD. Because of this, only four or five monkeys per oxime treatment were used in GF and VX experiments. Treatment with ATR/2-PAM or ATR/HI-6 substantially affected the slope of the agent dose-lethality response curves for GA and GB. Larger sample sires are required to estimate the shallow GA and GB dose lethality curves observed for oxime treated animals. For GA, 79 percent (11/14) of oxime treated animals injected with doses greater than 2 x lO-hr MLD survived at least 10 hr. These data indicate that both oximes provide some protection against a 2 x GA 10-hr MLD. For GB, ATR12-PAM treated animals were given doses ranging from approximately one to 13 x GB 1O-hr MLD, and ATR/HU-6 treated animals were administered GB doses ranging from approximately 0.75 to 2 x lO-hr MLD. In spite of the higher GB doses administered to ATR/2-PAM treated animals, survival was greater (718) than for ATR/HI-6 three animals (518). All three of the ATR/2-PAM treated animals injected with GB doses greater than 2 x lO-hr MLD survived.